BLOOD TRANSFUSION REACTIONS 

CLASSIFICATION 

A. Based on TIMING

Type

Onset

Acute

During transfusion or within 24 hours

Delayed

After 24 hours to weeks/months


B. Based on MECHANISM

Category

Examples

Immunological

AHTR, FNHTR, allergic, anaphylaxis, TRALI, GVHD

Non-immunological

TACO, bacterial sepsis, metabolic, hemolysis (mechanical), hypothermia


BLOOD TRANSFUSION REACTIONS – TABLE

Reaction

Time

Mechanism

Key Clinical Features

Acute hemolytic (AHTR)

Immediate

ABO mismatch

Fever +++, hypotension +++, hemolysis +++, back/flank pain, hemoglobinuria, no pulmonary edema

Febrile non-hemolytic (FNHTR)

Acute

Cytokines / anti-WBC antibodies

Fever +, chills, no hypotension, no hemolysis, no pulmonary edema

Allergic (urticarial)

Acute

IgE-mediated (plasma proteins)

Rash, pruritus, no fever, no hypotension, no hemolysis

Anaphylaxis

Immediate

Anti-IgA antibodies

Severe hypotension +++, shock, bronchospasm, angioedema, no fever, no hemolysis

TRALI

1–6 h

Anti-HLA / anti-neutrophil antibodies

Acute hypoxemia, non-cardiogenic pulmonary edema +++, ± fever, ± hypotension, no hemolysis

TACO

≤6 h

Volume overload

Pulmonary edema +++, hypertension, raised JVP, ± fever, no hemolysis

Bacterial sepsis

Acute

Bacterial contamination

High fever +++, rigors, severe hypotension +++, shock, ± pulmonary edema

Delayed hemolytic

Days–weeks

Alloantibodies (Rh, Kidd, Duffy, Kell)

Falling Hb, mild fever, hemolysis +, jaundice, no hypotension

TA-GVHD

2–30 days

Donor T-cells engraftment

Fever, skin rash, diarrhea, pancytopenia (fatal), no hemolysis

Iron overload

Chronic

Excess iron from repeated transfusions

Liver cirrhosis, cardiomyopathy, heart failure, endocrinopathies



ACUTE TRANSFUSION REACTIONS 

1. ACUTE HEMOLYTIC TRANSFUSION REACTION (AHTR) – MOST DANGEROUS

Cause

  • ABO incompatibility (most common)
  • Clerical error = most common cause
  • Preformed IgM antibodies complement activation


Pathophysiology

  1. Recipient anti-A/anti-B antibodies bind donor RBCs
  2. Complement activation (C5–C9)
  3. Intravascular hemolysis
  4. Release of:
    • Free hemoglobin AKI
    • Cytokines shock
    • Tissue factor DIC


Clinical Features (CLASSIC EXAM LIST)

  • Fever, chills
  • Severe back/flank pain
  • Chest pain
  • Dyspnea
  • Hypotension
  • Hemoglobinuria (cola-colored urine)
  • Bleeding (DIC)
  • Oliguria / anuria


Investigations

Test

Finding

Plasma

Pink/red (free Hb)

Urine

Hemoglobinuria

DAT (Coombs)

Positive

LDH

Bilirubin

indirect

Haptoglobin

PT/aPTT

(DIC)

Creatinine


Management (STEPWISE – VERY IMPORTANT)

  1. STOP transfusion immediately
  2. Maintain IV access with normal saline
  3. Inform blood bank
  4. Send:
    • Patient blood
    • Donor blood
    • Urine sample
  1. Supportive care:
    • Aggressive IV fluids
    • Maintain urine output (>1 mL/kg/hr)
    • Loop diuretics (if needed)
  1. Treat DIC if present
  2. Vasopressors if shock
  3. Dialysis if AKI


Prevention

  • Strict bedside identity check
  • Barcoding systems
  • Two-person verification


2. FEBRILE NON-HEMOLYTIC TRANSFUSION REACTION (FNHTR)

Definition

  • ≥1°C rise in temperature during or within 4 hours of transfusion
  • No hemolysis


Pathogenesis

  • Recipient antibodies against donor WBC antigens
  • Cytokines (IL-1, IL-6, TNF-α) accumulated during storage


Clinical Features

  • Fever
  • Chills, rigors
  • Malaise
  • Anxiety

## Diagnosis of exclusion rule out AHTR & sepsis first


Management

  • Stop transfusion temporarily
  • Paracetamol
  • Restart cautiously if symptoms resolve


Prevention

  • Leukoreduced blood products (most effective)


3. ALLERGIC TRANSFUSION REACTION

Cause

  • Hypersensitivity to plasma proteins


Types

Mild (Urticarial)

  • Itching
  • Flushing
  • Urticaria

Severe (Anaphylaxis) see below


Management (Mild)

  • Stop transfusion
  • Antihistamines
  • Restart if resolved


4. ANAPHYLACTIC TRANSFUSION REACTION

Cause

  • IgA deficiency in recipient
  • Anti-IgA antibodies react with donor IgA


Clinical Features

  • Sudden onset
  • Hypotension
  • Bronchospasm
  • Angioedema
  • Shock
  • No fever


Management

  1. Stop transfusion
  2. IM adrenaline
  3. Airway support
  4. IV fluids
  5. Steroids, antihistamines


Prevention

  • Washed RBCs
  • IgA-deficient plasma


5. TRALI (TRANSFUSION-RELATED ACUTE LUNG INJURY)

Definition

Acute hypoxemic respiratory failure within 6 hours of transfusion without cardiac failure


Pathogenesis (TWO-HIT HYPOTHESIS)

  1. Patient factors (sepsis, surgery) prime neutrophils
  2. Donor anti-HLA / anti-neutrophil antibodies activate them
  3. Endothelial injury capillary leak


Clinical Features

  • Acute dyspnea
  • Hypoxemia
  • Bilateral infiltrates
  • Fever ± hypotension
  • Normal JVP


Investigations

Test

Finding

CXR

Bilateral alveolar infiltrates

BNP

Normal

Echo

Normal LV


Management

  • Supportive only
  • Oxygen / ventilation
  • No diuretics
  • Avoid further transfusion from implicated donor


Prevention

  • Male-only plasma
  • Avoid multiparous female donors


6. TACO (TRANSFUSION-ASSOCIATED CIRCULATORY OVERLOAD)

Cause

  • Rapid or excessive transfusion
  • Elderly, CHF, CKD, pediatrics


Clinical Features

  • Dyspnea
  • Orthopnea
  • Hypertension
  • Raised JVP
  • Pulmonary edema


Differentiation: TRALI vs TACO (VERY HIGH-YIELD)

Feature

TRALI

TACO

Mechanism

Inflammatory

Volume overload

BP

Low/normal

High

JVP

Normal

Raised

BNP

Normal

High

Diuretics

Harmful

Beneficial


Management

  • Stop transfusion
  • Sit upright
  • Oxygen
  • Diuretics


7. BACTERIAL TRANSFUSION-TRANSMITTED SEPSIS

Cause

  • Platelets (room temperature) > RBCs
  • Common organisms:
    • Platelets Staph, Strep
    • RBCs Yersinia


Clinical Features

  • High fever
  • Rigors
  • Hypotension
  • Shock
  • DIC


Management

  • Stop transfusion
  • Broad-spectrum antibiotics
  • ICU support
  • Blood cultures


DELAYED TRANSFUSION REACTIONS


8. DELAYED HEMOLYTIC TRANSFUSION REACTION (DHTR)

Timeline

  • 3–14 days (can be weeks)


Cause

  • Anamnestic response to minor RBC antigens
    (Rh, Kidd, Duffy, Kell)


Features

  • Unexplained fall in Hb
  • Mild jaundice
  • Fever
  • Positive DAT


Management

  • Usually supportive
  • Avoid antigen-positive blood in future


9. TRANSFUSION-ASSOCIATED GRAFT-VERSUS-HOST DISEASE (TA-GVHD)

Cause

  • Viable donor T-lymphocytes engraft and attack host tissues


Risk Groups

  • Immunocompromised
  • Neonates
  • Intra-family transfusion
  • HLA-matched transfusion


Clinical Features (CLASSIC TRIAD)

  • Fever
  • Skin rash
  • Pancytopenia (fatal)


Prevention (ONLY EFFECTIVE MEASURE)

  • Irradiated blood products


10. IRON OVERLOAD (TRANSFUSIONAL HEMOSIDEROSIS)

Seen In

  • Thalassemia
  • MDS
  • Chronic transfusion dependence


Complications

  • Liver cirrhosis
  • Cardiomyopathy
  • Diabetes
  • Hypogonadism


Management

  • Iron chelation:
    • Deferoxamine
    • Deferasirox


METABOLIC & OTHER TRANSFUSION COMPLICATIONS

Complication

Mechanism

Key Point

Hypocalcemia

Citrate binds Ca²⁺

Massive transfusion

Hyperkalemia

K⁺ leak from stored RBCs

Neonates

Hypothermia

Cold blood

Arrhythmias

Coagulopathy

Dilution

Massive transfusion

Air embolism

Improper handling

Rare



ONE-LINE EXAM PEARLS

  • Most common fatal reaction AHTR
  • Most common overall reaction FNHTR
  • Most common cause of AHTR Clerical error
  • TRALI = non-cardiogenic pulmonary edema
  • TA-GVHD prevention irradiation
  • IgA deficiency anaphylaxis
  • Leukoreduction prevents FNHTR, CMV transmission